Related Experiment Videos
Combination of positive inotropic and vasodilating substances in congestive heart failure
1Section of Cardiology, Maggiore C.A. Pizzardi Hospital, Bologna, Italy.
Insights
Combining digoxin with vasodilators like molsidomine significantly improves cardiac function in congestive heart failure patients. This therapy enhances cardiac output without adverse effects, offering a powerful treatment option.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Congestive heart failure (CHF) management often involves combining inotropic agents with vasodilators.
- Vasodilators enhance inotropic drug effectiveness by reducing cardiac preload and/or afterload.
- Various inotropic drugs and vasodilators have shown positive results in combination therapies.
Purpose of the Study:
- To investigate the efficacy of combining digoxin with different vasodilators in patients with CHF.
- To evaluate the hemodynamic effects of digoxin combined with molsidomine, nifedipine, or captopril.
Main Methods:
- 42 patients with CHF were studied.
- Digoxin was administered intravenously (0.01 mg/kg).
- Combinations included digoxin with molsidomine (12 patients), nifedipine (22 patients), or captopril (8 patients).
Main Results:
- The combination of digoxin and molsidomine resulted in a greater reduction in left ventricular filling pressure (LVFP) than either agent alone.
- Hemodynamic improvement was observed without significant side effects.
- This effect was noted despite a substantial decrease in preload.
Conclusions:
- Combining digoxin with vasodilators is a potent strategy for improving cardiac function in CHF patients.
- Molsidomine, a nitrate-like agent, combined with digoxin, shows promise in managing CHF.
- This combination therapy offers hemodynamic benefits without compromising patient safety.
Abstract:
Therapy combining vasodilators and inotropic agents is considered to be one of the most powerful means of improving cardiac function in patients with congestive heart failure (CHF). The vasodilators enhance the effectiveness of inotropic agents by providing a reduction in preload and/or afterload. Inotropic drugs with different mechanisms of action, such as digitalis glycosides, ephedrine, dopamine, dobutamine, ibopamine, terbutaline, salbutamol, pirbuterol, prenalterol, amrinone, and milrinone, have been tested in combination with vasodilators with a predominant effect on preload (nitrates, molsidomine), with a predominant effect on afterload (hydralazine, nifedipine), or with a balanced action on both arterial and venous beds (nitroprusside, prazosin, captopril), showing positive results. The problem of the combination of digitalis glycosides and vasodilators with different sites of action has been considered by our group. In 42 patients with CHF, digoxin (DIG, 0.01 mg/kg intravenously) was tested in combination with molsidomine (MLS, 4 mg sublingually) (12 patients), a nitrate-like agent with a predominant vasodilating action on the capacitance vessels, nifedipine (NFP, 10 mg sublingually) (22 patients), a Ca2+ antagonist drug with a predominant action on the resistance vessels, and captopril (CPT, 25 mg orally) (8 patients), an ACE inhibitor with a balanced effect on both preload and afterload. The combination DIG plus MLS caused a reduction in left ventricular filling pressure (LVFP) greater than that achieved with either agent alone. The hemodynamic improvement was obtained without side effects, in spite of the striking fall in preload. We stress that this investigation was performed on patients with CHF following acute myocardial infarction.(ABSTRACT TRUNCATED AT 250 WORDS)